Natural Investments’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.72M Sell
14,557
-695
-5% -$80.2K 0.38% 54
2026
Q1
$1.82M Buy
15,252
+2,952
+24% +$387K 0.45% 45
2025
Q4
$1.67M Sell
12,300
-2,064
-14% -$297K 0.42% 50
2025
Q3
$2.12M Sell
14,364
-112
-0.8% -$15.5K 0.53% 48
2025
Q2
$1.87M Buy
14,476
+265
+2% +$32.1K 0.48% 55
2025
Q1
$1.7M Sell
14,211
-217
-2% -$26.9K 0.48% 57
2024
Q4
$1.67M Buy
+14,428
New +$1.82M 0.46% 58

Other funds holding XYL

Natural Investments's XYL Position: Q2 2026 in Review

Natural Investments reduced its Xylem (XYL) stake by 4.6% in Q2 2026, selling an estimated $80.2K and leaving 14,557 shares worth $1.72M. The position accounts for 0.38% of the portfolio, ranked #54.

Natural Investments first reported a position in XYL in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.12M in Q3 2025. 1,093 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Natural Investments held 14,557 shares of Xylem worth $1.72M as of Q2 2026.
  • Natural Investments sold 695 Xylem shares in Q2 2026, an estimated $80.2K.
  • Xylem made up 0.38% of Natural Investments's portfolio in Q2 2026, its #54 holding.
  • Natural Investments first reported a position in Xylem in Q4 2024 and has held it in 7 quarters since.
  • Natural Investments's Xylem position peaked at $2.12M in Q3 2025.
  • 1,093 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Natural Investments's 13F filing for Q2 2026, filed 31 Jul 2026.